He joins from Macleods Pharmaceuticals Ltd., where he spent more than six years. He started there in July 2020 as Senior General Manager and became Assistant Vice President in October 2023, also serving as P&L Head – International Business.

Earlier, he spent over five years at Emcure Pharmaceuticals across two stints. From 2003 to 2006 he was Senior Brand Manager / Group Product Manager, handling international marketing for the company’s overseas operations along with sales for Sri Lanka and Mauritius. He returned in 2015 as General Manager – Emerging Markets, and from April 2018 to July 2020 he was Associate Director / AVP (Sales & Marketing) – Emerging Markets, leading sales and marketing in Sri Lanka, Myanmar and Mauritius with responsibility for both top and bottom line.

Between his two Emcure stints, Gupta spent over eight years at Ranbaxy Laboratories. He was Group Brand Manager from December 2006, Senior Marketing Manager from December 2009, and Head of Marketing – Africa Business from April 2012 to April 2015. At Ranbaxy he was part of the launch of Synriam, the company’s first new chemical entity, and handled brands including Synasma. He began his career at Cipla in 2000, rising from Management Trainee to Brand Manager, with a focus on respiratory brands such as Asthalin and Foracort.

About USV Private Limited: USV is a Mumbai-headquartered pharmaceutical and healthcare company founded in 1961. It is ranked No. 1 in India in the oral anti-diabetic and cardiac segments, with trusted brands such as Glycomet and Ecosprin. Its portfolio spans more than 100 brands in India, and it has a presence in over 65 countries, with key markets in North America, Europe and the UK. In consumer healthcare, USV markets brands such as Sebamed (in partnership with Sebapharma) in baby care, skin care and hair care.